Equillium, Inc. filed a Form 144 with the SEC, detailing proposed insider sales including 30,975 shares "to be sold" and a noted 200,000-share sale. This filing signals upcoming or recent insider divestment activity.
Equillium Files Form 144 Indicating Insider Share Sales
EQInsider SellingForm 144BiotechnologyStock Data

